Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood
Cannabis use is common among adolescents and some research suggests that adolescent cannabis use increases the risk for depression, anxiety, and cognitive impairments in adulthood. In human studies, however, confounds may affect the association between cannabis use and the development of brain disorders.
These experiments investigated the effects of adolescent exposure to either cannabis smoke or THC on anxiety- and depressive-like behavior and cognitive performance in adulthood in Long-Evans rats.
Adolescent rats of both sexes were exposed to either cannabis smoke from postnatal days (P) 29–49 or ascending doses of THC from P35–45. When the rats reached adulthood (P70), anxiety-like behavior was investigated in the large open field and elevated plus maze, depressive-like behavior in the sucrose preference and forced swim tests, and cognitive function in the novel object recognition test.
Despite sex differences on some measures in the open field, elevated plus maze, forced swim, and novel object recognition tests, there were no effects of either adolescent cannabis smoke or THC exposure, and only relatively subtle interactions between exposure conditions and sex, such that sex differences on some performance measures were slightly attenuated.
Neither cannabis smoke nor THC exposure during adolescence produced robust alterations in adult behavior after a period of abstinence, suggesting that adverse effects associated with adolescent cannabis use might be due to non-cannabinoid concomitants of cannabis use.
KeywordsCannabis THC Depression Anxiety Cognition Behavior Adolescents Adult Sex differences Rats
We thank the NIDA Drug Supply Program for kindly providing the cannabis and placebo cigarettes and THC, and Shelby Blaes for assistance with THC preparation.
This work was supported by funding from the National Institutes of Health (R21 DA039349) to BS and AWB and the McKnight Brain Institute to BS, AWB, and MF.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Azofeifa A (2016) National estimates of marijuana use and related indicators—National Survey on Drug Use and Health, United States, 2002–2014. MMWR Surveill Summ 65Google Scholar
- Castagné V, Moser P, Porsolt RD (2009) Behavioral assessment of antidepressant activity in rodentsGoogle Scholar
- Coelho JE, Alves P, Canas PM, Valadas JS, Shmidt T, Batalha VL, Ferreira DG, Ribeiro JA, Bader M, Cunha RA (2014) Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety. Front Psych 5:67Google Scholar
- Gabrielsson J, Weiner D (2012) Non-compartmental analysis computational toxicology. Springer, pp 377–389Google Scholar
- Heuberger JA, Guan Z, Oyetayo O-O, Klumpers L, Morrison PD, Beumer TL, van Gerven JM, Cohen AF, Freijer J (2015) Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short-and long-term pharmacokinetics. Clin Pharmacokinet 54:209–219CrossRefGoogle Scholar
- Lepore M, Liu X, Savage V, Matalon D, Gardner EL (1996) Genetic differences in Δ9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci 58:PL365–PL372CrossRefGoogle Scholar
- Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA (2008) Adolescent rats find repeated Δ 9-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 33:1113–1126CrossRefGoogle Scholar
- Ravula A, Chandasana H, Setlow B, Febo M, Bruijnzeel AW, Derendorf H (2018) Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: an application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant. J Pharm Biomed Anal 160:119–125CrossRefGoogle Scholar
- Rubino T, Realini N, Braida D, Alberio T, Capurro V, Vigano D, Guidali C, Sala M, Fasano M, Parolaro D (2009a) The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox Res 15:291–302CrossRefGoogle Scholar
- Rubino T, Realini N, Braida D, Guidi S, Capurro V, Vigano D, Guidali C, Pinter M, Sala M, Bartesaghi R, Parolaro D (2009b) Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 19:763–772CrossRefGoogle Scholar
- Rubino T, Vigano D, Realini N, Guidali C, Braida D, Capurro V, Castiglioni C, Cherubino F, Romualdi P, Candeletti S, Sala M, Parolaro D (2008) Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 33:2760–2771CrossRefGoogle Scholar
- Zuardi A, Teixeira N, Karniol I (1984) Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats. Arch Int Pharmacodyn Ther 269:12–19Google Scholar